Scleroderma

HomePatientsLung Disease Week at the ATS2013Scleroderma ▶ Information for Experts
Information for Experts

Scleroderma Week

Clinician
ATS Educational Products

2013

B85 SCIENTIFIC BREAKTHROUGHS OF THE YEAR: MECHANISMS OF TISSUE REPAIR

2012

D86 IMPACT OF EXERCISE ON CARDIOPULMONARY STATUS: IMPLICATIONS FOR PULMONARY HYPERTENSION

Lung
Free CME/CNE Credits

The Scleroderma Foundation proudly announced its first ever free CME program for doctors and nurses earlier this year. Credits are available online. More credits will be offered in person in select cities. Check back for more updates.

Lung
Scleroderma Professional’s Membership Program

The Foundation’s membership program helps physicians and academics keep in touch with what is happening in scleroderma research.

Lung
Research Grant Program

The Scleroderma Foundation is a leading nonprofit supporter of scleroderma research.The Foundation budgets an average of $1 million each year to find the cause and cure of scleroderma.

Lung
Scleroderma Foundation Multi-Center Collaborative Grant

The Scleroderma Foundation’s newest research initiative involves multi-center research funding. It is an exciting opportunity for our research and treatment centers to work together to try and discover a cure. Find more information here.

Lung
Scleroderma Foundation Physician Books

The Scleroderma Foundation keeps a list of books that can be helpful to physicians. The list is available here:

www.scleroderma.org/physicianbooks




Clinician
ATS Journal articles on Scleroderma

Scleroderma: AJRCCM

Hemodynamic Predictors of Survival in Scleroderma-related Pulmonary Arterial Hypertension
Volume: 182, Issue: 2 (July 15, 2010)
Read Abstract

Gastroesophageal Reflux and Pulmonary Fibrosis in Scleroderma
Volume: 179, Issue: 5 (March 1, 2009)
Read Abstract

Borderline Pulmonary Arterial Pressure Is Associated with Decreased Exercise Capacity in Scleroderma
Volume: 180, Issue: 9 (November 1, 2009)
Read Abstract

Bronchoalveolar Lavage and Response to Cyclophosphamide in Scleroderma Interstitial Lung Disease
Volume: 177, Issue: 1 (January 1, 2008)
Read Abstract

Effects of 1-Year Treatment with Cyclophosphamide on Outcomes at 2 Years in Scleroderma Lung Disease
Volume: 176, Issue: 10 (November 15, 2007)
Read Abstract

Partitioning of Alveolar and Conducting Airway Nitric Oxide in Scleroderma Lung Disease
Volume: 165, Issue: 12 (June 15, 2002)
Read Abstract

Mast Cells' Contribution to the Fibrosing Alveolitis of the Scleroderma Lung
Volume: 147, Issue: 6_pt_1 (June, 1993)
Read Abstract

Scleroderma: AJRCMB

Resistin-Like Molecule-β in Scleroderma-Associated Pulmonary Hypertension
Volume: 41, Issue: 5 (November, 2009)
Read Abstract

Curcumin-Induced Apoptosis in Scleroderma Lung Fibroblasts: Role of Protein Kinase Cε
 Volume: 31, Issue: 1 (July, 2004)
Read Abstract

Gene Expression in Bronchoalveolar Lavage Cells from Scleroderma Patients
Volume: 26, Issue: 5 (May, 2002)
Read Abstract

Fibronectin Gene Polymorphisms Associated with Fibrosing Alveolitis in Systemic Sclerosis
Volume: 20, Issue: 1 (January, 1999)
Read Abstract

Scleroderma bronchoalveolar lavage fluid contains thrombin, a mediator of human lung fibroblast proliferation via induction of platelet-derived growth factor alpha-receptor.
Volume: 10, Issue: 4 (April, 1994)
Read Abstract

Scleroderma: Annals

State of the Art. Mechanisms of Scleroderma-induced Lung Disease
Volume: 4, Issue: 5 (August, 2007)
Read Abstract


Clinician
ATS Statements, Guidelines and Reports

ATS Statements, Guidelines and Reports are printed in the American Journal of Respiratory and Critical Care Medicine. These documents are also available in PDF format. You may download one copy of any ATS document; there is no charge for this service. Some examples below: